GLP-1 Agonists
The Real Cause of Obesity Is Not Calories
Discover why the caloric model fails and how 6 hormones actually control your weight. The science of the hormonal model explained.
12 min read
All articles in GLP-1 Agonists
Scientific articles on the mechanism of action and developments of GLP-1 agonist peptides.
GLP-1 Agonists Intermediate
Food Noise: The Voice Telling You to Eat (Guide)
Always thinking about food on a full stomach? It's called Food Noise: a biological signal, not willpower. Here's how to turn it off.
13 min read
GLP-1 Agonists Intermediate
Mounjaro (Tirzepatide): The Dual Agonist Explained
Mounjaro acts on 2 receptors (GLP-1 + GIP) with -22.5% weight loss in SURMOUNT trials. How it works, results, comparison with 1st and 3rd generation.
16 min read
GLP-1 Agonists Intermediate
Ozempic (Semaglutide): Everything You Need to Know in 2026
Ozempic works on 1 receptor (GLP-1), with -14.9% weight loss. Complete guide: how it works, limitations, adaptation signals, and 3rd-generation alternatives.
16 min read
GLP-1 Agonists Intermediate
Retatrutide: -28.7% Weight Loss — Full Guide 2026
Retatrutide targets GLP-1, GIP & Glucagon receptors. Up to -28.7% weight loss in 5,800-patient trials. Dosage, results & 2026 availability.
16 min read
GLP-1 Agonists Intermediate
Weight Loss Peptides: Frequently Asked Questions and Honest Answers
Complete FAQ on weight loss peptides: safety, legality in Europe, costs, real results, common fears. Answers based on published clinical trials.
22 min read
GLP-1 Agonists Intermediate
What Is Retatrutide? A Complete Scientific Overview
Retatrutide is a novel triple GIP/GLP-1/glucagon receptor agonist. Learn about its mechanism of action, clinical trial results, and weight loss potential.
6 min read
GLP-1 Agonists Intermediate
How GLP-1 Agonists Work for Weight Management
A comprehensive guide to GLP-1 receptor agonist mechanisms: from the incretin effect to appetite suppression and delayed gastric emptying.
7 min read
GLP-1 Agonists Intermediate
Retatrutide: Phase 2 and Phase 3 Clinical Trial Results
Detailed analysis of retatrutide clinical data: from the Phase 2 NEJM study to Eli Lilly's Phase 3 TRIUMPH program.
7 min read
GLP-1 Agonists Intermediate
The Incretin System Explained: GIP, GLP-1, and Glucagon
The incretin system explained: how GIP, GLP-1 and glucagon regulate metabolism, appetite and body weight. The science behind modern peptides.
8 min read
GLP-1 Agonists Intermediate
GLP-1 Peptide Adverse Effects: What the Research Shows
Analysis of documented GLP-1 receptor agonist side effects: nausea, gastrointestinal effects, long-term safety data and management.
13 min read
